BackBioMark Diagnostics Overview

BioMark Diagnostics Accounts Payable

BioMark Diagnostics's accounts payable is $79K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$79153.00
↓ 72.80% YoYΔ $-211806.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioMark Diagnostics Accounts Payable History

Loading

BioMark Diagnostics vs. peers: Accounts Payable Comparison

Loading

BioMark Diagnostics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioMark Diagnostics (BMKDF) FAQ

As of the most recent data (June 2026), BMKDF shows a accounts payable of $79K. That compares with $290K in the prior-year period — down 72.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BMKDF's accounts payable is now $79K (was $290K) — a 72.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioMark Diagnostics is outperforming or lagging.

Tracking BMKDF's accounts payable over time shows whether BioMark Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $79K That compares with $290K in the prior-year period — down 72.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has BioMark Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $79K) with ownership activity and broader fundamentals.